郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy.

期刊：Scientific reports发表年份：2017作者：Ilze Bot; Natalia V Ortiz Zacarías; Wilhelmus E A de Witte; Henk de Vries; Peter J van Santbrink; Daniël van der Velden; Mara J Kröner; Dirk-Jan van der Berg; Dean Stamos; Elizabeth C M de Lange; Johan Kuiper; Adriaan P IJzerman; Laura H Heitman
阅读更多 →

药效评价Synthesis, Characterization, and Evaluation of Difluoropyrido[4,3-b]indoles as Potential Agents for Acetylcholinesterase and Antiamnesic Activity.

期刊：Archiv der Pharmazie发表年份：2017作者：Malavalli Madaiah; Bidarur K Jayanna; Arakere S Manu; Maralekere K Prashanth; Hosakere D Revanasiddappa; Bantal Veeresh
阅读更多 →

药效评价Low-molecular-weight components of the metabolome control the proliferative activity in cellular and bacterial cultures.

期刊：Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections发表年份：2017作者：T Ya Vakhitov; N I Chalisova; S I Sitkin; T S Sall; O N Shalaeva; E V Demyanova; A S Morugina; A F Vinogradova; A V Petrov; A D Nozdrachev
阅读更多 →

药效评价In vitro evaluation of potential transporter-mediated drug interactions of evogliptin.

期刊：Biopharmaceutics & drug disposition发表年份：2017作者：Dae Y Lee; Hye W Chae; Hyun J Shim
阅读更多 →